Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 66.67% vs -96.41% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -143.78% vs 811.54% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -13.75% vs 47.71% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -46.67% vs -55.88% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of BioLineRx Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 150.00% vs -57.14% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 66.67% vs -96.41% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -10.96% vs -121.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -143.78% vs 811.54% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 15.74% vs -54.29% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -13.75% vs 47.71% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -11.11% vs -10.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -46.67% vs -55.88% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






